You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
China is among the front-runners in vaccine R&D, with one Chinese vaccine given conditional approval for general public use and several others currently undergoing clinical trials of various stages. (1/7)pic.twitter.com/ZBiVnR5o6D
Right now, public vaccination is underway in China. While striving to meet our huge domestic demand, we've been trying our best to advance vaccine cooperation with other countries through various means to offer them much-needed support and help. (2/7)
First, Chinese companies are conducting joint vaccine R&D with partners in a dozen countries, including clinical trials and co-production. (3/7)
Second, for countries that are in urgent need of vaccines, have certified Chinese vaccines, or authorized their emergency use, Chinese companies have started to export vaccines or to discuss relevant cooperation with them. 
(4/7)
Third, China has formally joined WHO-backed vaccine programme COVAX, supports G20 in promoting international vaccine cooperation, and upholds the role of multilateral cooperation in advancing the global equitable distribution of vaccines. (5/7)
So far, over 40 countries have asked to import Chinese vaccines. As the production capacity expands, China will be able to gradually offer more to countries in need. (6/7)
We look forward to seeing concrete actions from all sides to distribute more vaccines to developing countries and promote vaccines' equitable distribution and use worldwide, so that the day that sees our final victory over the virus will come sooner. (7/7)
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
